Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome

Myelodysplastic syndrome (MDS) is an aggressive and genetically heterogeneous disease with poor prognosis. Cellular immune disorder is a common characteristic of this disease and is thought to be related to clinical outcome. Alterations in T cell clonal expansion and T cell dysfunction has been dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xin, Chen, Cunte, Zhong, Mengjun, Geng, Suxia, Zhao, Yujie, Li, Minming, Deng, Chenxin, Zeng, Lingji, Wu, Ping, Lu, Zesheng, Weng, Jianyu, Du, Xin, Li, Yangqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193904/
https://www.ncbi.nlm.nih.gov/pubmed/34112264
http://dx.doi.org/10.1186/s40364-021-00302-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193904/
https://www.ncbi.nlm.nih.gov/pubmed/34112264
http://dx.doi.org/10.1186/s40364-021-00302-y

Ejemplares similares